Literature DB >> 7795834

Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.

V I Lasser1, J M Raczynski, V J Stevens, M K Mattfeldt-Beman, S Kumanyika, M Evans, E Danielson, A Dalcin, D M Batey, L K Belden.   

Abstract

Identifying effective, nonpharmacologic means of preventing or significantly delaying the onset of hypertension would be a major advance in the primary prevention of cardiovascular disease. In the first phase of the Trials of Hypertension Prevention (TOHP I), adults with high-normal diastolic blood pressure were randomly assigned to one of seven nonpharmacologic interventions. Only weight loss and reduction of dietary sodium proved to be effective strategies for reducing blood pressure. The second phase of TOHP (TOHP II) will test the effectiveness of weight loss, reduction of dietary sodium, and their combination of lowering blood pressure and preventing the onset of hypertension over a 3- to 4-year follow-up period. This article describes the three interventions used in TOHP II, methods used to maintain continued participation in this long-term trial, and protocol enhancements designed to maximize intervention effectiveness.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795834     DOI: 10.1016/1047-2797(94)00060-7

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  17 in total

Review 1.  Reduced dietary salt for the prevention of cardiovascular disease.

Authors:  Rod S Taylor; Kate E Ashton; Tiffany Moxham; Lee Hooper; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

2.  Psychosocial correlates of weight maintenance among black & white adults.

Authors:  Melanie Warziski Turk; Susan M Sereika; Kyeongra Yang; Linda J Ewing; Marilyn Hravnak; Lora E Burke
Journal:  Am J Health Behav       Date:  2012-03

3.  Hypertension Improvement Project (HIP) Latino: results of a pilot study of lifestyle intervention for lowering blood pressure in Latino adults.

Authors:  Maria Del Pilar Rocha-Goldberg; Leonor Corsino; Bryan Batch; Corrine I Voils; Carolyn T Thorpe; Hayden B Bosworth; Laura P Svetkey
Journal:  Ethn Health       Date:  2010-06       Impact factor: 2.772

4.  Personal digital assistant-based self-monitoring adherence rates in 2 dialysis dietary intervention pilot studies: BalanceWise-HD and BalanceWise-PD.

Authors:  Susan Stark; Linda Snetselaar; Beth Piraino; Roslyn A Stone; Sunghee Kim; Beth Hall; Lora E Burke; Mary Ann Sevick
Journal:  J Ren Nutr       Date:  2011-03-21       Impact factor: 3.655

Review 5.  African Americans in Standard Behavioral Treatment for Obesity, 2001-2015: What Have We Learned?

Authors:  Rachel W Goode; Mindi A Styn; Dara D Mendez; Tiffany L Gary-Webb
Journal:  West J Nurs Res       Date:  2017-02-01       Impact factor: 1.967

6.  The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: results from a multicenter randomized controlled trial.

Authors:  Keith M Diaz; Paul Muntner; Emily B Levitan; Michael D Brown; Dianne M Babbitt; Daichi Shimbo
Journal:  J Hypertens       Date:  2014-04       Impact factor: 4.844

7.  Economic evaluation of a worksite obesity prevention and intervention trial among hotel workers in Hawaii.

Authors:  Richard T Meenan; Thomas M Vogt; Andrew E Williams; Victor J Stevens; Cheryl L Albright; Claudio Nigg
Journal:  J Occup Environ Med       Date:  2010-01       Impact factor: 2.162

8.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP).

Authors:  Nancy R Cook; Jeffrey A Cutler; Eva Obarzanek; Julie E Buring; Kathryn M Rexrode; Shiriki K Kumanyika; Lawrence J Appel; Paul K Whelton
Journal:  BMJ       Date:  2007-04-20

Review 9.  Pre-hypertension: rationale for pharmacotherapy.

Authors:  Brent M Egan; Marilyn A Laken
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 10.  Prehypertension: risk stratification and management considerations.

Authors:  Brent M Egan; Stevo Julius
Journal:  Curr Hypertens Rep       Date:  2008-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.